Your browser doesn't support javascript.
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.
Kocarnik, Jonathan M; Compton, Kelly; Dean, Frances E; Fu, Weijia; Gaw, Brian L; Harvey, James D; Henrikson, Hannah Jacqueline; Lu, Dan; Pennini, Alyssa; Xu, Rixing; Ababneh, Emad; Abbasi-Kangevari, Mohsen; Abbastabar, Hedayat; Abd-Elsalam, Sherief M; Abdoli, Amir; Abedi, Aidin; Abidi, Hassan; Abolhassani, Hassan; Adedeji, Isaac Akinkunmi; Adnani, Qorinah Estiningtyas Sakilah; Advani, Shailesh M; Afzal, Muhammad Sohail; Aghaali, Mohammad; Ahinkorah, Bright Opoku; Ahmad, Sajjad; Ahmad, Tauseef; Ahmadi, Ali; Ahmadi, Sepideh; Ahmed Rashid, Tarik; Ahmed Salih, Yusra; Akalu, Gizachew Taddesse; Aklilu, Addis; Akram, Tayyaba; Akunna, Chisom Joyqueenet; Al Hamad, Hanadi; Alahdab, Fares; Al-Aly, Ziyad; Ali, Saqib; Alimohamadi, Yousef; Alipour, Vahid; Aljunid, Syed Mohamed; Alkhayyat, Motasem; Almasi-Hashiani, Amir; Almasri, Nihad A; Al-Maweri, Sadeq Ali Ali; Almustanyir, Sami; Alonso, Nivaldo; Alvis-Guzman, Nelson; Amu, Hubert; Anbesu, Etsay Woldu.
  • Kocarnik JM; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Compton K; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Dean FE; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Fu W; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Gaw BL; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Harvey JD; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Henrikson HJ; Department of Global Health, Boston University, Boston, Massachusetts.
  • Lu D; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Pennini A; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Xu R; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Ababneh E; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Abbasi-Kangevari M; Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
  • Abbastabar H; Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Abd-Elsalam SM; Advanced Diagnostic and Interventional Radiology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Abdoli A; Tropical Medicine Department, Tanta University, Tanta, Egypt.
  • Abedi A; Zoonoses Research Center, Jahrom University of Medical Sciences, Jahrom, Iran.
  • Abidi H; Department of Orthopaedic Surgery, University of Southern California, Los Angeles.
  • Abolhassani H; Laboratory Technology Sciences Department, Yasouj University, Yasuj, Iran.
  • Adedeji IA; Department of Laboratory Medicine, Karolinska University Hospital, Huddinge, Sweden.
  • Adnani QES; Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran.
  • Advani SM; Department of Sociology, Olabisi Onabanjo University, Ago-Iwoye, Nigeria.
  • Afzal MS; Department of Midwifery, Karya Husada Institute of Health Sciences, Kediri, Indonesia.
  • Aghaali M; Department of Midwifery, Auckland University of Technology, Auckland, New Zealand.
  • Ahinkorah BO; Terasaki Institute for Biomedical Innovation, Los Angeles, California.
  • Ahmad S; School of Medicine, Georgetown University, Washington, DC.
  • Ahmad T; Department of Life Sciences, University of Management and Technology, Lahore, Pakistan.
  • Ahmadi A; Department of Epidemiology and Biostatistics, Qom University of Medical Sciences, Qom, Iran.
  • Ahmadi S; The Australian Centre for Public and Population Health Research, University of Technology Sydney, Sydney, New South Wales, Australia.
  • Ahmed Rashid T; Foundation University Medical College, Foundation University Islamabad, Islamabad, Pakistan.
  • Ahmed Salih Y; Department of Epidemiology and Health Statistics, Southeast University, Nanjing, China.
  • Akalu GT; Department of Epidemiology and Biostatistics, Shahrekord University of Medical Sciences, Shahrekord, Iran.
  • Aklilu A; Department of Epidemiology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Akram T; School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Akunna CJ; Department of Computer Science and Engineering, University of Kurdistan Hewler, Erbil, Iraq.
  • Al Hamad H; Database Technology Department, Sulaimani Polytechnic University, Sulaymaniyah, Iraq.
  • Alahdab F; College of Informatics, Sulaimani Polytechnic University, Sulaymaniyah, Iraq.
  • Al-Aly Z; Microbiology, Immunology and Parasitology Department, St Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
  • Ali S; Microbial, Cellular and Molecular Biology, Addis Ababa University, Addis Ababa, Ethiopia.
  • Alimohamadi Y; Department of Medical Laboratory Sciences, Arba Minch University, Arba Minch, Ethiopia.
  • Alipour V; School of Mathematical Sciences, University of Science Malaysia, Penang, Malaysia.
  • Aljunid SM; Department of Public Health, Intercountry Centre for Oral Health for Africa, Jos, Nigeria.
  • Alkhayyat M; Department of Public Health, Federal Ministry of Health, Garki, Nigeria.
  • Almasi-Hashiani A; Geriatric and Long-Term Care Department, Hamad Medical Corporation, Doha, Qatar.
  • Almasri NA; Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Al-Maweri SAA; Mayo Evidence-Based Practice Center, Mayo Clinic Foundation for Medical Education and Research, Rochester, Minnesota.
  • Almustanyir S; John T. Milliken Department of Internal Medicine, Washington University in St Louis, St Louis, Missouri.
  • Alonso N; Clinical Epidemiology Center, Department of Veterans Affairs, St Louis, Missouri.
  • Alvis-Guzman N; Department of Information Systems, Sultan Qaboos University, Muscat, Oman.
  • Amu H; Pars Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Anbesu EW; Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran.
JAMA Oncol ; 8(3): 420-444, 2022 Mar 01.
Article in English | MEDLINE | ID: covidwho-1664325
ABSTRACT
IMPORTANCE The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden.

OBJECTIVE:

To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. EVIDENCE REVIEW The GBD 2019 estimation methods were used to describe cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs) in 2019 and over the past decade. Estimates are also provided by quintiles of the SDI, a composite measure of educational attainment, income per capita, and total fertility rate for those younger than 25 years. Estimates include 95% uncertainty intervals (UIs).

FINDINGS:

In 2019, there were an estimated 23.6 million (95% UI, 22.2-24.9 million) new cancer cases (17.2 million when excluding nonmelanoma skin cancer) and 10.0 million (95% UI, 9.36-10.6 million) cancer deaths globally, with an estimated 250 million (235-264 million) DALYs due to cancer. Since 2010, these represented a 26.3% (95% UI, 20.3%-32.3%) increase in new cases, a 20.9% (95% UI, 14.2%-27.6%) increase in deaths, and a 16.0% (95% UI, 9.3%-22.8%) increase in DALYs. Among 22 groups of diseases and injuries in the GBD 2019 study, cancer was second only to cardiovascular diseases for the number of deaths, years of life lost, and DALYs globally in 2019. Cancer burden differed across SDI quintiles. The proportion of years lived with disability that contributed to DALYs increased with SDI, ranging from 1.4% (1.1%-1.8%) in the low SDI quintile to 5.7% (4.2%-7.1%) in the high SDI quintile. While the high SDI quintile had the highest number of new cases in 2019, the middle SDI quintile had the highest number of cancer deaths and DALYs. From 2010 to 2019, the largest percentage increase in the numbers of cases and deaths occurred in the low and low-middle SDI quintiles. CONCLUSIONS AND RELEVANCE The results of this systematic analysis suggest that the global burden of cancer is substantial and growing, with burden differing by SDI. These results provide comprehensive and comparable estimates that can potentially inform efforts toward equitable cancer control around the world.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Global Burden of Disease / Neoplasms Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: JAMA Oncol Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Global Burden of Disease / Neoplasms Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: JAMA Oncol Year: 2022 Document Type: Article